scientifyRESEARCH
research funding database

This opportunity is currently closed.

Sign up for Content alerts to stay informed when this or related funding opportunities are posted.

RESEARCH FUNDING

2023 SITC-Mallinckrodt Pharmaceuticals Adverse Events in Cancer Immunotherapy Clinical Fellowship (worldwide)

Share

Text on a blue background says "Want to find funding & get support for grant-writing?" Logos of scientifyRESEARCH & GrantDesk appear below on a white background and an orange plus symbol appears between the two logos.
Text on a blue background says "Want to find funding & get support for grant-writing?" Logos of scientifyRESEARCH & GrantDesk appear below on a white background and an orange play symbol appears between the two logos. An arrow mark points to the logos.

The 2023 SITC-Mallinckrodt Pharmaceuticals Adverse Events in Cancer Immunotherapy Clinical Fellowship from the Society for Immunotherapy of Cancer (SITC) with funding from Mallinckrodt Pharmaceuticals, supports a postdoctoral researcher, resident, research scientist, or comparable position, working on furthering research and translation of adverse events in cancer immunotherapy. Applicants must be a member of the SITC and hold an MD, PhD or MD/PhD degree. Applications are open to candidates worldwide. The fellowship provides funding of 40,000 USD over 1 year plus financial support to attend SITC´s 38th Annual Meeting.

Applications close on March 27, 2023.

Full application due:
March 27, 2023

non member

More related info for you

Register for free

Don´t have an account?

Start with our free trial to enjoy our 7 days of unlimited grant access and our premium features.

or, Choose a plan to subscribe to our premium membership.

Be the first to know

Sign-up for Personalized Grant alerts

Logo3

Sign-up for our
monthly research
funding newsletter

You can unsubscribe at any time.